Jump to Content
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Recently viewed
(0)
Save Entry
Searches
(0)
Recently viewed
(0)
Save Search
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Featured Online Content
Supplements
NCCN Meeting Highlights
JNCCN In the News
NCCN News
Highlights of the NCCN Oncology Research Program
Video Roundtables
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Conexiant (FKA Harborside)
Reducing Disparities in Cancer Care
Search
Close
Advanced Search
Help
CLO22-068: An Assessment of Extended Pembrolizumab Dosing and Outcomes in Advanced Non-Small Cell Lung Cancer Patients During the COVID-19 Pandemic
Authors:
Gordon Taylor Moffat
Gordon Taylor Moffat
Kingston Health Sciences Centre, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Gordon Taylor Moffat in
Current site
Google Scholar
PubMed
Close
MD
,
Lilian Hanna
Lilian Hanna
Kingston Health Sciences Centre, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Lilian Hanna in
Current site
Google Scholar
PubMed
Close
DO
,
Wilma Hopman
Wilma Hopman
Kingston Health Sciences Centre, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Wilma Hopman in
Current site
Google Scholar
PubMed
Close
BA, MA
,
Andrea S. Fung
Andrea S. Fung
Kingston Health Sciences Centre, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Andrea S. Fung in
Current site
Google Scholar
PubMed
Close
MD, PhD
, and
Pierre-Olivier Gaudreau
Pierre-Olivier Gaudreau
Kingston Health Sciences Centre, Queen’s University, Kingston, Ontario, Canada
Canadian Cancer Trials Group, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Pierre-Olivier Gaudreau in
Current site
Google Scholar
PubMed
Close
MD, PhD
View More
View Less
Volume/Issue:
Volume 20: Issue 3.5
Online Publication Date:
31 Mar 2022
DOI:
https://doi.org/10.6004/jnccn.2021.7269
Restricted access
Get Citation Alerts
Article Details
Corresponding Author: Gordon Taylor Moffat, MD
Print
Save
Cite
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://jnccn.org/abstract/journals/jnccn/20/3.5/article-pCLO22-068.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Collapse
Expand
Top
Journal of the National Comprehensive Cancer Network
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Article Information
Copyright:
Copyright © 2022 by the National Comprehensive Cancer Network 2022
Article Category:
Abstract
Print Publication Date:
31 Mar 2022
Online Publication Date:
31 Mar 2022
Get Permissions
Cited By
PubMed
Article by Gordon Taylor Moffat
Article by Lilian Hanna
Article by Wilma Hopman
Article by Andrea S. Fung
Article by Pierre-Olivier Gaudreau
Google Scholar
Article by Gordon Taylor Moffat
Article by Lilian Hanna
Article by Wilma Hopman
Article by Andrea S. Fung
Article by Pierre-Olivier Gaudreau
Similar articles in Google Scholar
Related Articles
Metrics
Metrics
All Time
Past Year
Past 30 Days
Abstract Views
0
0
0
Full Text Views
471
117
44
PDF Downloads
0
0
0
EPUB Downloads
0
0
0
[18.97.14.82]
18.97.14.82
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
View Expanded
View Table
View Full Size